Can a capsaicin patch ease diabetic foot pain? new study investigates
NCT ID NCT06495424
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether repeated use of QUTENZA (a capsaicin 8% patch) can reduce pain and the need for painkillers in adults with painful diabetic nerve damage in the feet. About 144 participants will receive up to three patch applications, each 12 weeks apart. Researchers will track pain scores, quality of life, and medication use to see if the treatment works in real-world settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
capsaicin 8% patch (QUTENZA)
What this could lead to
If successful, this could provide real-world evidence that repeated QUTENZA treatments safely reduce diabetic nerve pain and the need for pain medications.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. It is also small (144 people) and only looks at short-term effects over three treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAINFUL DIABETIC NEUROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Interventional Pain and Spine
Wilmington, Delaware, 19808, United States
-
Center for Interventional Pain and Spine
Bryn Mawr, Pennsylvania, 19010, United States
-
Center for Interventional Pain and Spine
Fort Washington, Pennsylvania, 19034, United States
-
Center for Interventional Pain and Spine
Lancaster, Pennsylvania, 17601, United States
-
Curalta Clinical Trials
Oradell, New Jersey, 07649, United States
-
Horizon Clinical Research
Gainesville, Georgia, 30501, United States
-
Horizon Clinical Research
Jasper, Georgia, 30143, United States
-
Horizon Clinical Research
Newnan, Georgia, 30265, United States
-
Iqra Research
Edgewood, Kentucky, 41017, United States
-
Iqra Research
Cincinnati, Ohio, 45248, United States